Pulmonary valve agenesis is a rare congenital heart condition where the pulmonary valve does not form normally before birth. In pulmonary valve agenesis, blood flow from the heart to the lungs can become abnormal, and babies often have breathing trouble, bluish skin, feeding problems, or signs of heart failure soon after birth. Some children are recognized before birth on ultrasound, while others are diagnosed in infancy, and pulmonary valve agenesis is usually lifelong. Not everyone will have the same experience. Treatment often involves careful monitoring, medicines to support the heart and lungs, and heart surgery, and the outlook depends on how severe the heart and airway changes are.
How many people live with Pulmonary valve agenesis?
About 13 million people worldwide are living with heart problems present from birth, also called congenital heart defects (Global Burden of Disease Study, 2019), and about 2.4 million people in the United States are living with one of these conditions (CDC, 2024). Since pulmonary valve agenesis is widely reported to make up only about 0.2% to 0.4% of congenital heart defects, this suggests an estimated roughly 26,000 to 53,000 people worldwide and about 4,800 to 9,600 in the U.S. may be living with it, rather than a direct counted total (StatPearls, 2024).
Overview
Pulmonary valve agenesisSymptoms
Pulmonary valve agenesis is a rare birth defect. Babies often have breathing trouble, noisy breathing, bluish skin, poor feeding, and trouble gaining weight; some also have a heart murmur or frequent chest infections.
Outlook and prognosis
Pulmonary valve agenesis can range from a serious newborn heart problem to a milder condition managed into adulthood. Outlook depends mainly on how much the enlarged lung arteries affect breathing, whether other heart differences are present, and how well surgery helps.
Causes and risk factors
Pulmonary valve agenesis usually develops before birth, often from a random change in early heart development. It can occur with chromosome differences or genetic syndromes, especially 22q11.2 deletion. Most cases are not caused by lifestyle or environmental exposures.
Genetic influences
Genetics can matter in pulmonary valve agenesis, but many cases happen without a clearly found inherited cause. Some are linked to chromosome changes or syndromes, so genetic testing may help guide care and family planning.
Diagnosis
Diagnosis of pulmonary valve agenesis usually starts with clinical features and a heart murmur. Echocardiography confirms the missing or severely underdeveloped valve and related heart changes. Some babies also have genetic tests to look for an associated syndrome.
Treatment and drugs
Pulmonary valve agenesis is usually treated with heart surgery, often early in life, to improve blood flow and reduce strain on the lungs. Many living with pulmonary valve agenesis also need regular heart imaging, medicines for symptoms, and follow-up with a congenital heart specialist.
Symptoms
Breathing can be hard from the start, especially during feeds, crying, or sleep. The early features of pulmonary valve agenesis often show up in newborns or infancy, though the degree can vary widely. For many people with pulmonary valve agenesis, the main day-to-day issues are breathing trouble and tiring easily because the heart and lungs are under extra strain. Some babies are very sick soon after birth, while others have milder signs at first.
Babies often breathe quickly and may seem to work hard for each breath, with the ribs pulling in. This can become more obvious during feeding, crying, or when lying flat.
Wheezing, harsh breathing, or a rattly sound can happen when enlarged blood vessels press on the airways. Some infants have repeated episodes of breathing distress, especially during colds.
The lips, tongue, or skin may look bluish or gray when oxygen levels are low. This may be easier to notice during crying, feeding, or other exertion.
Feeding can be slow and tiring because breathing and sucking are harder to coordinate. Many babies need frequent pauses, sweat with feeds, or take in less milk than expected.
How people usually first notice Pulmonary valve agenesis?
Pulmonary valve agenesis is usually first noticed before birth on a prenatal ultrasound or soon after birth, when a baby has trouble breathing, breathes very fast, looks bluish around the lips or skin, or has a heart murmur that a doctor hears through a stethoscope. The first signs of pulmonary valve agenesis often happen because blood flow from the heart to the lungs is abnormal and the nearby lung airways can be squeezed, which can cause noisy breathing, wheezing, or repeated breathing distress in the newborn period. In some babies, doctors first suspect it during an early heart scan called an echocardiogram, especially if there are other heart differences such as tetralogy of Fallot.
Types of Pulmonary valve agenesis
No distinct types of Pulmonary valve agenesis are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that diet, exercise, supplements, or other lifestyle changes can meaningfully delay when symptoms begin in pulmonary valve agenesis, because this is a heart problem that is present from birth. What can help is early care with a heart specialist who treats heart conditions people are born with, since regular checkups and heart scans can find breathing problems or strain on the heart early, and some people need surgery or another procedure to treat these problems, but that manages complications rather than preventing the condition itself. Staying closely connected to your care team may help many living with pulmonary valve agenesis do as well as possible, even though it cannot guarantee when or whether symptoms will appear.
What genetics can tell you about symptoms
Genetics can sometimes help explain why pulmonary valve agenesis happens and whether it appears along with other heart or body differences, especially when it is part of a broader genetic condition such as a chromosome change like 22q11.2 deletion. In people with pulmonary valve agenesis, though, genes usually do not predict symptoms very precisely on their own; day-to-day problems and severity are often shaped more by the exact heart structure, how much blood leaks backward, and whether enlarged blood vessels press on the airways. This means genetic testing may give clues about related features and overall risk, but it usually cannot say for sure which symptoms will appear or exactly when they will start.
Causes and risk factors
For many families, the exact causes of pulmonary valve agenesis are not fully known. A genetic change is the clearest known cause in some babies, especially a missing piece of chromosome 22 called 22q11.2 deletion. This change may be inherited from a parent, or it may happen for the first time in the baby. Family history can be one part of the story, but lifestyle and environment add their own chapters. Pregnancy exposures and health conditions can also raise the risk of pulmonary valve agenesis, including poorly controlled diabetes, smoking, alcohol, infections, or certain medicines.
What are the most common causes or risk factors?
Pulmonary valve agenesis is a rare heart problem that starts very early in pregnancy, when the valve between the heart and the lungs does not form as expected, and in many babies the exact cause is not clear. Genes can play a role, especially if there is a family history of heart defects or if the baby has a small missing piece of genetic material called 22q11.2 deletion, and this condition often happens along with other heart differences. Most of the time it is not caused by anything a parent did, but some pregnancy factors that raise the chance of birth defects in general, such as poorly controlled diabetes or certain medicines taken during pregnancy, may also increase risk.
Environmental and biological risk factors
Pulmonary valve agenesis develops very early in pregnancy, when the developing baby's heart is forming. Because it is rare, the risk factors for pulmonary valve agenesis are usually discussed in the broader group of congenital heart differences rather than as one single proven cause. Doctors often group risks into internal (biological) and external (environmental). In many pregnancies, no clear reason is found.
Pulmonary valve agenesis often begins as part of a broader change in how the fetal heart forms during the first weeks of pregnancy. When this early development is disrupted, nearby heart structures may also be more likely to form differently.
Diabetes before pregnancy or in early pregnancy can increase the chance of congenital heart differences. The risk is higher when blood sugar is not well controlled during the period when the heart is forming.
Certain infections during early pregnancy, especially rubella, can interfere with normal heart development. Timing matters most in the first trimester, when the heart's basic structure is being built.
Some medicines known to affect fetal development can raise the risk of heart defects when taken early in pregnancy. The exact risk depends on the specific drug, the dose, and when the exposure happens.
Genetic risk factors
For many families, the exact genetic cause of pulmonary valve agenesis is never fully identified. Most cases are not traced to one clearly inherited gene, but some are linked to chromosome changes or broader genetic conditions that affect how the heart forms before birth. When people ask about the genetic causes of pulmonary valve agenesis, the best-known link is a small missing piece of chromosome 22 called 22q11.2 deletion. Carrying a genetic change doesn’t guarantee the condition will appear.
22q11.2 deletion: A small missing piece of chromosome 22 is the strongest known genetic link in some babies with pulmonary valve agenesis. It is more likely to be found when this heart problem occurs along with other complex heart differences or features outside the heart.
Family history: Having a close relative with a congenital heart defect can raise the chance of pulmonary valve agenesis, although the overall risk usually remains low. This suggests that some families share inherited factors that influence early heart development.
Sporadic cases: Many people with pulmonary valve agenesis have no family history and no single clear inherited cause. In these cases, the condition may reflect a new genetic change or several genetic influences acting together early in fetal development.
Rare syndromes: Less often, pulmonary valve agenesis appears as part of a broader genetic syndrome or chromosome difference. If a baby also has unusual facial features, growth concerns, or developmental issues, genetic testing may help look for one of these rarer causes.
Lifestyle risk factors
Pulmonary valve agenesis is a congenital heart condition, so lifestyle habits do not cause it. However, how lifestyle affects pulmonary valve agenesis can be important for breathlessness, exercise tolerance, strain on the heart, and the risk of complications over time. The most helpful focus is on habits that reduce cardiopulmonary stress and support day-to-day symptom control.
Exercise does not cause pulmonary valve agenesis, but the wrong intensity can worsen shortness of breath, palpitations, or fatigue. Activity plans usually need to be individualized so movement supports fitness without overloading the right side of the heart. In people with airway compression or limited exercise tolerance, supervised or clinician-guided activity may be safer than strenuous unsupervised training.
Smoking or vaping can aggravate airway irritation and reduce breathing efficiency, which may be especially problematic when enlarged pulmonary arteries already affect the airways. Avoiding tobacco smoke may help limit cough, wheeze, and added cardiopulmonary stress.
Excess body weight can increase the work of breathing and place extra demand on the heart, making symptoms more noticeable in pulmonary valve agenesis. Maintaining a healthy weight may improve exercise tolerance and reduce overall strain during daily activities.
Diet does not create the condition, but high-salt eating patterns can worsen fluid retention in people who develop heart failure symptoms. Balanced nutrition also supports energy levels, recovery, and overall heart health when ongoing cardiac monitoring or treatment is needed.
Risk prevention
Pulmonary valve agenesis is a birth defect present before birth, so there is usually no guaranteed way to prevent the condition itself. For many families, prevention focuses on lowering the chance of some congenital heart defects before and during pregnancy, and on reducing complications if a baby is born with pulmonary valve agenesis. Prevention is about lowering risk, not eliminating it completely.
Seeing a doctor before pregnancy can help review medicines, long-term health conditions, and family history that may affect the risk of birth defects. Good control of diabetes and avoiding known harmful drugs can lower risk for some heart problems in a developing baby.
Taking folic acid before conception and in early pregnancy is recommended because it lowers the risk of some major birth defects. It may not specifically prevent pulmonary valve agenesis, but it is a standard step for healthier early development.
Avoiding alcohol, smoking, and non-prescribed drugs during pregnancy may help reduce the risk of congenital heart defects. Limiting exposure to harmful chemicals and discussing all medicines with a clinician also matters.
Staying up to date on vaccines before pregnancy and reducing exposure to certain infections can support healthy fetal development. This is especially important for infections known to affect the developing heart.
Can you prevent Pulmonary valve agenesis?
In most cases, no, pulmonary valve agenesis cannot be fully prevented; it is a rare heart birth difference where the valve that should help blood flow from the heart to the lungs does not form normally early in pregnancy. Good pregnancy care may lower the chance of some heart birth differences overall, especially by managing diabetes, avoiding alcohol and smoking, and checking medicines with a doctor, but these steps do not guarantee prevention of this condition.
Transmission
Pulmonary valve agenesis is a rare heart condition present from birth, and it is not infectious, so it cannot be caught from or passed to someone else through contact, coughing, sex, or shared spaces. In most families, it happens for the first time while a baby’s heart is forming early in pregnancy, rather than being directly passed down from a parent.
Less often, Pulmonary valve agenesis can be linked to an underlying genetic change or a broader genetic condition, so how Pulmonary valve agenesis is inherited can vary from one family to another. If this condition has been diagnosed, genetic counseling can help explain the chance of it happening again in a future pregnancy.
When to test your genes
Because pulmonary valve agenesis is a congenital heart defect, genetic testing is usually most useful at or soon after diagnosis, especially if there are other heart differences, developmental concerns, or a family history of congenital heart disease. Testing can look for syndromes such as 22q11.2 deletion, which may guide care and family planning.
Diagnosis
Pulmonary valve agenesis is usually diagnosed when a baby or child is found to have a heart murmur, breathing problems, bluish skin, or feeding trouble, though some cases are first noticed on a prenatal scan. The diagnosis of pulmonary valve agenesis is based on the heart’s structure and blood flow pattern rather than symptoms alone. Early and accurate diagnosis can help you plan ahead with confidence.
A clinician often hears an unusual heart murmur and may notice fast breathing, poor weight gain, or low oxygen levels. These findings do not confirm pulmonary valve agenesis by themselves, but they help show that detailed heart testing is needed.
This simple test measures how much oxygen is in the blood using a small sensor on the skin. Low readings can support concern for a congenital heart problem, especially in newborns with breathing or color changes.
This ultrasound of the heart is the main test used to confirm pulmonary valve agenesis. It can show that the pulmonary valve is missing or severely underdeveloped, how blood moves through the right side of the heart, and whether nearby pulmonary arteries are enlarged.
Some cases are suspected before birth during routine pregnancy imaging or a specialized fetal echocardiogram. These scans can show abnormal blood flow and associated heart differences, helping the care team prepare for delivery and early treatment.
How is Pulmonary valve agenesis diagnosed?
Doctors usually diagnose pulmonary valve agenesis with a heart ultrasound, called an echocardiogram, which can show that the valve carrying blood from the heart to the lungs is missing or very poorly formed and may also show enlarged blood vessels near the lungs. It may be found before birth on a pregnancy ultrasound, or after birth when a baby has fast or noisy breathing, trouble feeding, bluish skin, or a heart murmur. Doctors sometimes use other tests, such as a chest X-ray, heart tracing, or more detailed heart scans, to see how severe it is, and genetic testing may be offered if there are signs of a related genetic condition, but the main diagnosis comes from heart imaging.
Stages of Pulmonary valve agenesis
Pulmonary valve agenesis does not have defined progression stages. This is because it is a structural heart problem present from birth, and its effects can vary from one baby, child, or adult to another rather than moving through set steps over time. Often the process begins when you notice changes in daily life, such as fast breathing, tiring with feeds or activity, or repeated chest infections, and doctors confirm the condition with a heart exam and an ultrasound scan of the heart called an echocardiogram. Monitoring usually focuses on how severe the heart and airway problems are, whether there are early symptoms of pulmonary valve agenesis getting worse, and whether more imaging or specialist follow-up is needed over time.
Outlook and prognosis
Outlook in pulmonary valve agenesis varies widely and depends mainly on how severe the airway compression, pulmonary artery enlargement, and associated heart defects are. Infants with marked respiratory distress often need early surgical repair and can face significant illness in the neonatal period, while people with milder forms may survive into childhood or adulthood with ongoing cardiology follow-up. Prognosis is generally better when airway obstruction is limited and repair can successfully reduce pulmonary regurgitation and relieve compression of the bronchi. Even after treatment, some patients have persistent problems such as right ventricular dilation, arrhythmias, exercise intolerance, or repeated respiratory infections. Mortality is highest in the most severely affected newborns, especially those with major airway compromise or complex associated congenital heart disease, but survival has improved substantially with modern surgical and intensive care. Long-term outcome is therefore highly individualized and usually depends on both cardiac function and respiratory status over time.
Long-term effects
Pulmonary valve agenesis can have lasting effects on breathing, heart function, and day-to-day stamina from infancy into adult life. Because the missing or severely underformed valve often occurs along with other heart changes, the long-term effects of pulmonary valve agenesis can vary widely from one person to another. In medical terms, these are sometimes called late effects or chronic symptoms, although for a congenital condition they are better thought of as long-term health consequences.
Many living with pulmonary valve agenesis have enlarged pulmonary arteries that can press on the airways over time. This can lead to ongoing noisy breathing, repeated chest infections, or reduced exercise tolerance, especially when airway compression is severe.
The right side of the heart often has to handle abnormal blood flow for years. Over time, this can stretch the right ventricle and make it less efficient at pumping blood forward.
If strain on the heart builds up, some people with pulmonary valve agenesis develop long-term heart failure features such as poor stamina, swelling, or trouble keeping up with normal activity. The risk depends on how severe the heart defect is and whether other heart problems are present.
Scarring, chamber enlargement, and long-standing pressure changes can raise the chance of irregular heartbeats. These rhythm problems may appear later in childhood or adulthood and can range from brief palpitations to more serious arrhythmias.
How is it to live with Pulmonary valve agenesis?
Living with pulmonary valve agenesis can look very different from one person to another, because the condition often occurs along with other heart differences and can range from severe in infancy to more manageable later on. Many people living with it deal with shortness of breath, tiring easily, trouble with exercise, and sometimes breathing problems caused by enlarged pulmonary arteries pressing on the airways, so daily life may revolve around heart checkups, medicines, surgery or catheter-based care, and pacing activity to match energy and symptoms. For parents, partners, and other loved ones, this can mean extra worry, frequent medical appointments, and adjusting routines around symptoms, recovery, and monitoring, but with expert cardiology care, many families find a rhythm that supports both safety and a meaningful daily life.
Treatment and drugs
Pulmonary valve agenesis is usually treated by a heart team, because people with this condition often need care for both blood flow problems and pressure on the airways. Treatment often looks different for each person, but it commonly includes close monitoring, medicines to help with heart failure symptoms if they occur, and surgery to improve how blood moves from the heart to the lungs. In babies or children with more severe pulmonary valve agenesis, surgery may be needed early to rebuild or replace the missing valve area and, when possible, reduce enlargement of the lung arteries that can press on the breathing tubes. After treatment, many living with pulmonary valve agenesis still need regular follow-up with a congenital heart specialist, since needs can change over time and some may need more than one procedure as they grow.
Can you cure Pulmonary valve agenesis?
No, pulmonary valve agenesis cannot be cured in the usual sense, because it means the valve between the heart and lungs did not form before birth. Treatment usually focuses on surgery and ongoing heart care to improve blood flow, ease breathing problems, and lower the risk of complications. Many people living with this condition can do much better with treatment, but they often need regular follow-up over time.
Non-drug treatment
Living with pulmonary valve agenesis often means managing both heart and breathing issues, sometimes from infancy onward. For many, treatment begins not at the pharmacy, but with careful monitoring, procedures, and day-to-day support that help the heart and lungs work as well as possible. The right plan depends on how severe the valve problem is, whether the airways are being squeezed by enlarged blood vessels, and how well a child or adult is growing and staying active. Non-drug treatment for pulmonary valve agenesis is usually guided by a heart team with experience in congenital heart conditions.
Surgery is often the main treatment when pulmonary valve agenesis causes major blood flow problems or pressure on the airways. Doctors may rebuild the outflow from the right side of the heart and reduce the size of enlarged lung arteries if they are pressing on breathing tubes.
Some people need catheter-based procedures to check pressures or treat related heart problems without open surgery. These treatments use thin tubes placed through blood vessels and can sometimes delay or complement surgery.
Regular visits with a congenital heart specialist help track heart function, oxygen levels, and signs that symptoms are changing. Echocardiograms and sometimes MRI or CT scans are used over time to guide decisions about timing of treatment.
When enlarged lung arteries narrow the airways, breathing support can become an important part of care. Supportive therapies can include oxygen, noninvasive breathing support, or airway clearance techniques to help with wheezing, infections, or tiring easily during feeds and activity.
Your genes may have an impact on how drugs work for you
For people living with pulmonary valve agenesis, genetic changes are important mainly because they can help explain how the heart developed this way, not because they usually tell doctors which medicine will work best. Most medicines used around this condition, such as those that help with breathing, fluid buildup, or heart strain, are chosen based on symptoms, age, body size, and how the heart and lungs are working, rather than on genetic test results. In some families, this heart problem is part of a broader genetic condition, and that can sometimes affect the overall care plan, but there is no widely used gene-based drug matching for this condition at this time.
Pharmacological treatments
Medicines for pulmonary valve agenesis are mainly used to ease symptoms and support the heart and lungs while doctors plan monitoring or surgery. No drug can replace the missing or severely underdeveloped pulmonary valve, so treatment is tailored to problems such as fluid buildup, breathing trouble, or irregular heart rhythms. In many living with pulmonary valve agenesis, the exact drug plan depends on age, anatomy, and whether heart failure or airway compression is present. Finding the right medication can be a process of trial, patience, and adjustment.
Furosemide is commonly used to reduce extra fluid when pulmonary valve agenesis leads to heart failure symptoms such as fast breathing or poor feeding. Some doctors also use bumetanide or spironolactone, especially when swelling or lung congestion is hard to control.
Captopril, enalapril, or lisinopril may be used to lower the heart’s workload in some children or adults with weakened pumping function. These medicines are not right for everyone, so blood pressure, kidney function, and potassium usually need follow-up checks.
Digoxin may be prescribed in selected cases when the heart is not pumping well or symptoms of heart failure continue despite other treatment. It needs careful dosing, especially in infants, because too much can cause side effects or rhythm problems.
If irregular heartbeats develop, doctors may use medicines such as propranolol, atenolol, sotalol, or amiodarone depending on the type of arrhythmia. Not everyone responds to the same medication in the same way, so treatment is matched to the heart rhythm pattern and overall heart function.
Genetic influences
When a baby is born with pulmonary valve agenesis, families often want to know why it happened and whether it could happen again. It’s natural to ask whether family history plays a role. In some cases, pulmonary valve agenesis is linked to changes in genes or chromosomes that affect how the heart forms before birth, especially when it happens along with other heart differences. One well-known example is a small missing piece of chromosome 22, called 22q11.2 deletion, which can be found in some children with this condition. For many families, though, the genetic causes of pulmonary valve agenesis are not clear, and it may happen as a one-time change during early development rather than through a strong inherited pattern. If pulmonary valve agenesis is found before or after birth, genetic testing and counseling can help clarify whether there is an underlying syndrome and what it may mean for future pregnancies.
Is Pulmonary valve agenesis genetic?
Genetics can matter in pulmonary valve agenesis, but many cases happen without a clearly found inherited cause. Some are linked to chromosome changes or syndromes, so genetic testing may help guide care and family planning.
Having a genetic risk is not necessarily a diagnosis
Gene variants are common in the general population and are a normal part of human biology. Most do not directly affect health and instead reflect the natural diversity seen among people. For many genes, having a variant connected with a condition suggests a possible association rather than a certain diagnosis, especially when several genes and environmental factors contribute. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families living with pulmonary valve agenesis, treatment is usually shaped first by how much the missing or very small pulmonary valve affects breathing, blood flow, and the size of the blood vessels going to the lungs. Doctors often use heart scans, oxygen levels, and symptoms to decide whether a baby or child needs surgery, breathing support, or medicines to ease fluid buildup or help the heart work more efficiently. Not every difference in response is genetic, but a genetic diagnosis can still shape care because pulmonary valve agenesis sometimes happens as part of a broader inherited condition that may also affect growth, calcium levels, immunity, or development. When that is the case, genetic testing for pulmonary valve agenesis can help the care team look for related health issues and plan surgery, anesthesia, and follow-up more safely. Direct gene-based drug matching is not yet a routine part of treatment for pulmonary valve agenesis, and medicine choices are usually guided more by age, weight, heart function, and other medical problems than by a specific gene result. Even so, knowing whether there is an underlying genetic condition can help doctors tailor overall treatment to the whole child, not just the heart.
Interactions with other conditions
Many living with pulmonary valve agenesis have symptoms that are shaped not just by the heart problem itself, but also by breathing issues and other congenital conditions that can happen alongside it. This is because pulmonary valve agenesis often comes with very enlarged blood vessels near the lungs, which can press on the airways and make wheezing, repeated chest infections, or shortness of breath more likely. Another important aspect is how it may link with other diseases: some people also have related heart differences present from birth, which can add to strain on the heart and affect when treatment is needed. Pulmonary valve agenesis can also appear as part of a broader genetic condition, including 22q11.2 deletion syndrome, so doctors may sometimes suggest a genetics evaluation if there are other physical findings or developmental concerns. Interactions can look very different from person to person. For many, this can mean that early symptoms of pulmonary valve agenesis are first noticed during feeding, exercise, or frequent respiratory illnesses, and care works best when heart, lung, and sometimes genetics specialists coordinate closely.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Pulmonary valve agenesis?
Pulmonary valve agenesis can look a lot like other heart problems present from birth, especially ones that reduce blood flow to the lungs or involve a hole between the heart’s lower pumping chambers, because these can also cause fast breathing, bluish lips or skin, poor feeding, and tiring easily. It can also be mistaken for lung problems such as asthma, bronchiolitis, or repeated chest infections when wheezing and noisy breathing are the main signs. Doctors usually tell them apart with a heart ultrasound and other imaging tests.
History
Long before modern heart scans were available, doctors occasionally described babies and children with severe breathing problems and unusual blood flow through the right side of the heart. Some of these early reports likely included pulmonary valve agenesis, although the condition was not always recognized clearly at the time. Because it is uncommon and often occurs along with other heart differences, early descriptions were usually based on what doctors heard through a stethoscope, saw at surgery, or found after death rather than on a full picture of how the heart was working.
As imaging improved in the 20th century, pulmonary valve agenesis became easier to identify during life. In recent decades, awareness has grown as echocardiography and later fetal ultrasound allowed doctors to see the missing or severely underdeveloped pulmonary valve, the enlarged lung arteries, and the strain this can place on breathing. This helped explain why some newborns seemed to struggle not only because of the heart itself, but also because swollen blood vessels near the airways could make breathing harder.
Over time, doctors also learned that pulmonary valve agenesis is often part of a broader pattern of heart development rather than an isolated finding. Many living with pulmonary valve agenesis have other structural heart differences, and this helped specialists sort the condition into more precise medical categories. What once might have seemed like a confusing mix of symptoms, such as a blue tint to the skin, fast breathing, poor feeding, or repeated chest infections, gradually became a recognizable diagnosis with a clearer clinical course.
The history of pulmonary valve agenesis is also tied to major advances in treatment. Earlier in the last century, options were limited, and severe cases often had poor outcomes. As pediatric heart surgery, intensive care, and imaging improved, more children could be diagnosed earlier and treated more effectively. For families today, that history matters because it explains why the outlook for pulmonary valve agenesis is very different now than it was in older medical reports, especially when care begins early and is guided by a team experienced in congenital heart disease.